More than a year after entering the ownership of the Triton fund, Bormioli Pharma is carrying out a thorough review of its corporate policies, redefining brand identity and objectives, while underling its loyalty to the core business of a specialized supplier of the pharmaceutical market, with integrated containers of hollow and plastic glass, tamper evident closures and accessories.